1-3 of 3
Vladimir Lj Lazarevic
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Impact of treatment delay in acute myeloid leukemia revisited

Clinical Trials & Observations
Gunnar Juliusson, Oskar Hagberg, Vladimir Lj Lazarevic, Sören Lehmann, Martin Höglund
Journal: Blood Advances
Blood Adv (2021) 5 (3): 787–790.
https://doi.org/10.1182/bloodadvances.2020003806
Published: 2021
Includes: Supplemental data
Journal Articles

The prognostic impact of FLT3 -ITD and NPM1 mutation in adult AML is age-dependent in the population-based setting

Clinical Trials & Observations
Gunnar Juliusson, Martin Jädersten, Stefan Deneberg, Sören Lehmann, Lars Möllgård, Lovisa Wennström, Petar Antunovic, Jörg Cammenga, Fryderyk Lorenz, Emma Ölander, Vladimir Lj Lazarevic, Martin Höglund
Journal: Blood Advances
Blood Adv (2020) 4 (6): 1094–1101.
https://doi.org/10.1182/bloodadvances.2019001335
Published: 2020
Includes: Supplemental data
Journal Articles

Agonistic targeting of TLR1/TLR2 induces p38 MAPK-dependent apoptosis and NFκB-dependent differentiation of AML cells

Mia Eriksson, Pablo Peña-Martínez, Ramprasad Ramakrishnan, Marion Chapellier, Carl Högberg, Gabriella Glowacki, Christina Orsmark-Pietras, Talía Velasco-Hernández, Vladimir Lj Lazarević, Gunnar Juliusson, Jörg Cammenga, James C. Mulloy, Johan Richter, Thoas Fioretos, Benjamin L. Ebert, Marcus Järås
Journal: Blood Advances
Blood Adv (2017) 1 (23): 2046–2057.
https://doi.org/10.1182/bloodadvances.2017006148
Published: 2017
Includes: Supplemental data